v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) (PARENTHETICAL)
$ in Millions
 9 Months Ended
Sep. 29, 2019
USD ($)
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed $ 8,233 [1]
GSK Consumer Healthcare [Member]  
Equity method investment, ownership percentage 32.00%
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed $ 8,200
Fair value of equity method investment 15,700
Net assets contributed 7,600
Cash conveyed $ 146
[1] The $8.2 billion Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed for the nine months ended September 29, 2019 reflects the receipt of a 32% equity-method investment in the new company valued at $15.7 billion in exchange for net assets contributed of $7.6 billion and is presented in operating activities net of $146 million cash conveyed that is reflected in Other investing activities, net. See Note 2B.See Notes to Condensed Consolidated Financial Statements.